Literature DB >> 20944647

Nevi, family history, and fair skin increase the risk of second primary melanoma.

Victor Siskind1, Maria Celia B Hughes, Jane M Palmer, Judith M Symmons, Joanne F Aitken, Nicholas G Martin, Nicholas K Hayward, David C Whiteman.   

Abstract

Although risk factors for primary cutaneous melanoma are well defined, relatively little is known about predictors for second primary melanoma. Given the rising incidence of this cancer, coupled with improvements in survival, there is a prevalent and growing pool of patients at risk of second primary melanomas. To identify the predictors of second primary melanoma, we followed a cohort of 1,083 Queensland patients diagnosed with incident melanoma between 1982 and 1990 and who completed a baseline questionnaire. During a median follow-up of 16.5 years, 221 patients were diagnosed with at least one additional primary melanoma. In multivariate analyses, second primary melanomas were associated with high nevus count (hazard ratio (HR), 2.91; 95% confidence interval (CI) 1.94-4.35), high familial melanoma risk (HR, 2.12; 95% CI 1.34-3.36), fair skin (HR, 1.51; 95% CI 1.06-2.16), inability to tan (HR, 1.66; 95% CI 1.13-2.43), an in situ first primary melanoma (HR, 1.36; 95% CI 0.99-1.87), and male sex (HR, 1.49; 95% CI 1.12-2.00). Patients whose first primary was lentigo maligna melanoma (HR, 1.80; 95% CI 1.05-3.07) or nodular melanoma (HR, 2.13; 95% CI 1.21-3.74) had higher risks of subsequent primaries than patients whose first primary tumor was superficial spreading melanoma. These characteristics could be assessed in patients presenting with first primary melanoma to evaluate risk of developing a second primary.

Entities:  

Mesh:

Year:  2010        PMID: 20944647      PMCID: PMC3045696          DOI: 10.1038/jid.2010.298

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

1.  A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.

Authors:  Colin B Begg; Amanda J Hummer; Urvi Mujumdar; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Stephen B Gruber; Hoda Anton Culver; Roberto Zanetti; Richard P Gallagher; Terrence Dwyer; Timothy R Rebbeck; Klaus Busam; Lynn From; Marianne Berwick
Journal:  Int J Epidemiol       Date:  2006-03-23       Impact factor: 7.196

2.  Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.

Authors:  Michael Coory; Peter Baade; Joanne Aitken; Mark Smithers; G Roderick C McLeod; Ian Ring
Journal:  Cancer Causes Control       Date:  2006-02       Impact factor: 2.506

3.  Clinicopathological features of and risk factors for multiple primary melanomas.

Authors:  Cristina R Ferrone; Leah Ben Porat; Katherine S Panageas; Marianne Berwick; Allan C Halpern; Ami Patel; Daniel G Coit
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

4.  The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.

Authors:  Marianne Berwick; Irene Orlow; Amanda J Hummer; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Stephen B Gruber; Hoda Anton-Culver; Roberto Zanetti; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Peter A Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Homer Wilcox; Colin B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

5.  Genetic and environmental influences in the development of multiple primary melanoma.

Authors:  A D Burden; J Newell; N Andrew; G Kavanagh; J M Connor; R M MacKie
Journal:  Arch Dermatol       Date:  1999-03

6.  Multiple primary melanoma: two-year results from a population-based study.

Authors:  Linda Titus-Ernstoff; Ann E Perry; Steven K Spencer; Jennifer Gibson; Jiao Ding; Bernard Cole; Marc S Ernstoff
Journal:  Arch Dermatol       Date:  2006-04

7.  The incidence of second primary invasive melanoma in Queensland, 1982-2003.

Authors:  Kieran A McCaul; Lin Fritschi; Peter Baade; Michael Coory
Journal:  Cancer Causes Control       Date:  2008-01-01       Impact factor: 2.506

8.  The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.

Authors:  Amanda J Baxter; Maria Celia Hughes; Marina Kvaskoff; Victor Siskind; Sri Shekar; Joanne F Aitken; Adele C Green; David L Duffy; Nicholas K Hayward; Nicholas G Martin; David C Whiteman
Journal:  Twin Res Hum Genet       Date:  2008-04       Impact factor: 1.587

9.  The Queensland Familial Melanoma Project: study design and characteristics of participants.

Authors:  J F Aitken; A C Green; R MacLennan; P Youl; N G Martin
Journal:  Melanoma Res       Date:  1996-04       Impact factor: 3.599

10.  Melanoma incidence and mortality in Scotland 1979-2003.

Authors:  R M MacKie; C Bray; J Vestey; V Doherty; A Evans; D Thomson; M Nicolson
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

View more
  8 in total

Review 1.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

Review 2.  Targeted inhibition of BRAF kinase: opportunities and challenges for therapeutics in melanoma.

Authors:  Rolando Pérez-Lorenzo; Bin Zheng
Journal:  Biosci Rep       Date:  2012-02       Impact factor: 3.840

3.  Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.

Authors:  Eric J Stanelle; Klaus J Busam; Barrie S Rich; Emily R Christison-Lagay; Ira J Dunkel; Ashfaq A Marghoob; Allan Halpern; Daniel G Coit; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2015-03-14       Impact factor: 2.545

4.  Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.

Authors:  Maris S Jones; Hitoe Torisu-Itakura; Devin C Flaherty; Hans F Schoellhammer; Jihey Lee; Myung-Shim Sim; Mark B Faries
Journal:  Am Surg       Date:  2016-10       Impact factor: 0.688

5.  Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men.

Authors:  Andrew C Walls; Jiali Han; Tricia Li; Abrar A Qureshi
Journal:  Am J Epidemiol       Date:  2013-04-11       Impact factor: 4.897

6.  A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.

Authors:  A E Cust; C Badcock; J Smith; N E Thomas; L E Haydu; B K Armstrong; M H Law; J F Thompson; P A Kanetsky; C B Begg; Y Shi; A Kricker; I Orlow; A Sharma; S Yoo; S F Leong; M Berwick; D W Ollila; S Lo
Journal:  Br J Dermatol       Date:  2019-11-27       Impact factor: 9.302

7.  Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20-22 February 2020.

Authors:  Christina W Lee; J Gregory McKinnon; Noelle Davis
Journal:  Curr Oncol       Date:  2021-05-27       Impact factor: 3.677

8.  New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway.

Authors:  Trude E Robsahm; Margaret R Karagas; Judy R Rees; Astri Syse
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.